|
Re: I wonder...
|
9
|
Resverlogix Corp.
|
Jan 22, 2020 08:51PM
|
|
My guess is a second BTD is coming
|
9
|
Resverlogix Corp.
|
Feb 08, 2020 09:20AM
|
|
Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
10
|
Resverlogix Corp.
|
Mar 24, 2020 08:12AM
|
|
Re: the happening/not happening scale
|
10
|
Resverlogix Corp.
|
Apr 09, 2020 02:13PM
|
|
Re: AGM & PP
|
10
|
Resverlogix Corp.
|
Nov 24, 2020 07:49AM
|
|
Presentation May 12th
|
10
|
Resverlogix Corp.
|
May 05, 2021 09:16PM
|
|
Re: The problem...as I see it
|
11
|
Resverlogix Corp.
|
Oct 19, 2020 08:29AM
|
|
Re: Musings
|
11
|
Resverlogix Corp.
|
Jun 10, 2020 11:03PM
|
|
Endpoints article about Pfizer and M&A
|
11
|
Zenith Epigenetics
|
Apr 29, 2020 10:34AM
|
|
June 9th NR
|
11
|
Resverlogix Corp.
|
Jun 14, 2020 10:44AM
|
|
Re: New RVX Tweet
|
12
|
Resverlogix Corp.
|
Jul 28, 2020 04:26PM
|
|
Resverlogix Reports Filing of New Intellectual Property on Key Renal Protection and Glucose Control Markers
|
12
|
Resverlogix Corp.
|
Nov 02, 2020 07:38AM
|
|
Re: Financial Clues to the RVX Puzzle
|
13
|
Resverlogix Corp.
|
Mar 14, 2020 12:07PM
|
|
BETonMACE details
|
13
|
Resverlogix Corp.
|
May 16, 2018 06:09PM
|
|
News report on last NR
|
13
|
Resverlogix Corp.
|
Mar 05, 2021 07:55PM
|
|
Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
14
|
Resverlogix Corp.
|
Jun 22, 2020 07:06AM
|
|
Covid and apabetalone
|
18
|
Resverlogix Corp.
|
Oct 20, 2020 09:28PM
|
